NeuroBo Pharmaceuticals
OrganisationROR
Kind
Company
ROR, ror.org
Trials
Phase 2, Completed, 2023, 109 people, 26 Sept 2023, clinicaltrials.gov
Phase 2, Completed, 2003, 277 people, 30 Oct 2015, clinicaltrials.gov
Phase 1, Completed, 2002, 20 people, 27 Oct 2015, clinicaltrials.gov
Phase 1, Completed, 2000, 20 people, 27 Oct 2015, clinicaltrials.gov